SARAH MITCHUM: Open Payments
NPI 1356807507 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 48 payments from 16 companies in 2025. Trend: 2023 $1,043 · 2024 $1,080 · 2025 $941
Food & beverage: $842Education: $99
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $205 |
| Novo Nordisk Inc | 10 | $193 |
| Amgen Inc. | 5 | $83 |
| SHIELD THERAPEUTICS INC | 4 | $71 |
| PFIZER INC. | 4 | $65 |
| Lilly USA, LLC | 3 | $51 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $38 |
| Ardelyx, Inc. | 2 | $35 |
| ABBVIE INC. | 2 | $33 |
Products named: Veozah, Ozempic, ACCRUFER, Wegovy, NURTEC ODT, IBSRELA, MOUNJARO, EVENITY.
Industry payments across GA — which companies pay providers there.
